MARIANA VARNER: Open Payments
NPI 1093276867 · ALPHARETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,096 in 90 payments from 15 companies in 2025. Trend: 2023 $1,443 · 2024 $1,487 · 2025 $2,096
Food & beverage: $2,096
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 14 | $541 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 22 | $360 |
| Gilead Sciences, Inc. | 15 | $340 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $198 |
| Ipsen Biopharmaceuticals, Inc | 4 | $111 |
| ABBVIE INC. | 6 | $109 |
| Janssen Biotech, Inc. | 5 | $87 |
| Novo Nordisk Inc | 3 | $83 |
| Regeneron Healthcare Solutions, Inc. | 2 | $66 |
| Boston Scientific Corporation | 2 | $49 |
Products named: REZDIFFRA, XIFAXAN, ENTYVIO, IQIRVO, TREMFYA, DUPIXENT, Wegovy, RINVOQ.
Industry payments across GA — which companies pay providers there.
